MedPath

pper extremity strength in children and adolescents with and without unilateral Cerebral Palsy

Recruiting
Conditions
brain lesion
Cerebral Palsy
10014623
Registration Number
NL-OMON41425
Lead Sponsor
niversiteit Maastricht
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
400
Inclusion Criteria

Children with CP:
* child diagnosed with CP, unilateral or bilateral with a clear difference between the left and right side
* age between 7 and 18 years
* GMFCS level I-III
* MACS level I-III
* enough intellectual ability to understand easy tasks
* children and their parents/caregivers should comprehend and speak Dutch;Typically developing children:
* attending regular primary or secondary school
* age between 7 - 18 years
* children and their parents/caregivers should comprehend and speak Dutch

Exclusion Criteria

Children withCP:
* surgical intervention < 6 months
* Botulinum Toxin A treatment in the upper extremity in the past 6 months
* Contractures in the upper extremity disturbing functional use;Typical developing children:
* Muscle disease
* Injuries, fractures or casting of the upper extremity in the past 6 months

Study & Design

Study Type
Observational non invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>Primary outcome measures: the most important psychometric property to<br /><br>investigate in terms of muscle strength evaluation is reproducibility.<br /><br>Reproducibility in this study will be assessed by looking at the following<br /><br>factors: Intraclass Correlation Coefficient (ICC), Limits Of Agreement (LOA),<br /><br>Standard Error of Measurement (SEM) en de Smallest Detectable Difference (SDD).<br /><br>Reference values for upper extremity muscle strength in children and<br /><br>adolescents will be determined by using the Generalized Additive Models for<br /><br>Location, Scale, and Shape (GAMLSS) method. </p><br>
Secondary Outcome Measures
NameTimeMethod
<p>not applicable</p><br>
© Copyright 2025. All Rights Reserved by MedPath